References
- Fava M, Davidson KG: Definition and epidemiology of treatmentresistant depression. Psychiatric Clinics of North America 1996; 19(2):179–200
- Petersen T, Dording C, Neault NB, Kornbluh R, Alpert JE, Nierenberg AA, Rosenbaum JF, Fava M: A survey of prescribing practices in the treatment of depression. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26(1):177–87
- Nierenberg AA, Wright EC: “Evolution of remission as the new standard in the treatment of depression.” J Clin Psychiatry. 1999; 60(suppl); 22: 7–1
- Fava M, Kaji J: Continuation and maintenance treatments of major depressive disorder. Psych Annals 1994; 42:281–290
- Mischoulon D, Fava M, Rosenbaum JF: Strategies for augmentation of SSRI treatment: A survey of an academic psychopharmacology practice. Harv Rev Psychiatry 1999; 6(6):322–326
- Fredman SJ, Fava M, Kienke AS, White CN, Nierenberg AA, Rosenbaum JF: Partial response, nonresponse, and relapse with selective serotonin reuptake inhibitors in major depression: a survey of current "next-step" practices. J Clin Psychiatry 2000; 61(6):403–8
- Guy W (ed): ECDEU Assessment Manual for Psychopharmacology, revised. DHEW Pub. No. (ADM) 76–338.. Rockville, MD: National Institute of Mental Health, 1976
- Fava M: Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 2003; 53(8):649–59
- Posternak MA, Zimmerman M: Switching versus augmentation: A prospective, naturalistic comparison in depressed, treatmentresistant patients. J Clin Psychiatry 2001; 62(2):135–42
- Hylan TR, Meneades L, Crown WH, Sacristan JA, Gilaberte I, Montejo AL: SSRI antidepressant use patterns and their relation to clinical global impression scores: A naturalistic study. J Affect Disord 1999; 52(1–3):111–9
- Rush AJ, Bose A, Heydorn WE: Naturalistic study of the early psychiatric use of citalopram in the United States. Depress Anxiety 2002; 16(3):121–7
- Posternak MA, Zimmerman M: Short-term spontaneous improvement rates in depressed outpatients.. J Nerv Ment Dis 2000; 188(12):799–804
- Sporn J, Ghaemi SN, Sambur MR, Rankin MA, Recht J, Sachs GS, Rosenbaum JF, Fava M: Pramipexole augmentation in the treatment of unipolar and bipolar depression: A retrospective chart review. Ann Clin Psychiatry 2000; 12(3):137–40
- Faries D, Herrera J, Rayamajhi J, DeBrota D, Demitrack M, Potter WZ: The responsiveness of the Hamilton Depression Rating Scale. J Psychiatr Res 2000; 34(1):3–10
- Fava M, Burt T, Batzar E, Sackeim H: Conditional probability of remission at 8 weeks given early global improvement in major depressive disorder. European Neuropsychopharmacology 2003; 13(4):S214
- Hamilton M: A rating scale for depression. Journal of Neurology Neurosurgery and Psychiatry 1960; 23:56–62
- First BM, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders — Patient Edition (SCID I/P). Biometrics Research Department, New York State Psychiatric Institute, 1995